These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 35870)

  • 21. A comparison of hematopoiesis after treatment with antithymocyte serum and erythropoietin.
    Kinnamon KE; Blackwell LH; Ledney GD
    Exp Hematol; 1974; 2(4):204-11. PubMed ID: 4616844
    [No Abstract]   [Full Text] [Related]  

  • 22. Antilymphocytic antibodies and marrow transplantation. IV. Comparison of the effects of antibody fragments directed against immunoglobulin or lymphocyte antigens on acute secondary disease.
    Rodt H; Therfelder S; Eulitz M
    Exp Hematol; 1974; 2(4):195-203. PubMed ID: 4156327
    [No Abstract]   [Full Text] [Related]  

  • 23. [Effect of antithymocyte globulin on bone marrow colony-forming capacity during defective myelopoiesis].
    Torubarova NA; Krasina NA; Vladimirskaia EB; Soldatova MA
    Biull Eksp Biol Med; 1981 Apr; 91(4):483-5. PubMed ID: 6973376
    [TBL] [Abstract][Full Text] [Related]  

  • 24. GVHD suppression by incubation of bone marrow grafts with anti-T-cell globulin: effect in the canine model and application to clinical bone marrow transplantation.
    Rodt H; Kolb HJ; Netzel B; Rieder I; Janka G; Belohradsky B; Haas RJ; Thierfelder S
    Transplant Proc; 1979 Mar; 11(1):962-6. PubMed ID: 377731
    [No Abstract]   [Full Text] [Related]  

  • 25. [Suppression of antibody formation by bone marrow T-cells activated by histocompatibility antigens].
    Gambarov SS; Khaitov RM
    Biull Eksp Biol Med; 1977 Mar; 83(3):300-2. PubMed ID: 322761
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Effect of the treatment of parental cells in vitro with anti-T antibody on bone marrow transplantation in F1 hybrid mice.
    Hrubá A; Paluska E; Fricová V; Fiala J
    Folia Biol (Praha); 1980; 26(5):338-50. PubMed ID: 7002637
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Adaptive phenomena in bone marrow transplantation.
    Goujet-Zalc C; Ilbery PL
    Exp Hematol; 1973; 1(1):3-10. PubMed ID: 4154047
    [No Abstract]   [Full Text] [Related]  

  • 28. Engraftment of allogeneic dog bone marrow.
    Vriesendorp HM; Zurcher C; van Bekkum DW
    Transplant Proc; 1975 Dec; 7(4):465-8. PubMed ID: 825
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Effect of antithymocyte globulin pretreatment on immunological reconstitution of lethally irradiated animals.
    Allen EM; Gengozian N
    Transplantation; 1975 Jun; 19(6):456-63. PubMed ID: 237349
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Effect of anti-T-cell globulin on GVHD in leukemic patients treated with BMT.
    Rodt H; Kolb HJ; Netzel B; Haas RJ; Wilms K; Götze CB; Link H; Thierfelder S
    Transplant Proc; 1981 Mar; 13(1 Pt 1):257-61. PubMed ID: 7022835
    [No Abstract]   [Full Text] [Related]  

  • 31. Use of low doses of homozygous allogeneic bone marrow cells to induce tolerance with antilymphocyte serum (ALS): tolerance by intraorgan injection.
    Monaco AP; Gozzo JJ; Wood ML; Liegeois A
    Transplant Proc; 1971 Mar; 3(1):680-3. PubMed ID: 4398509
    [No Abstract]   [Full Text] [Related]  

  • 32. Studies of marrow transplantation in dogs.
    Storb R; Weiden PL; Graham TC; Thomas ED
    Transplant Proc; 1976 Dec; 8(4):545-9. PubMed ID: 11585
    [No Abstract]   [Full Text] [Related]  

  • 33. Treatment of aplastic anemia: results with bone marrow transplantation, antithymocyte globulin, and a monoclonal anti-T cell antibody.
    Champlin R; Ho W; Bayever E; Winston DJ; Lenarsky C; Feig SA; Gale RP
    Prog Clin Biol Res; 1984; 148():227-38. PubMed ID: 6379661
    [No Abstract]   [Full Text] [Related]  

  • 34. Use of total lymphoid irradiation (TLI) in bone marrow and organ transplantation.
    Strober S; Gottlieb M; Slavin S; Hoppe R; Grumet FC; Kaplan HS
    Transplant Proc; 1979 Dec; 11(4):1930-3. PubMed ID: 43614
    [No Abstract]   [Full Text] [Related]  

  • 35. Use of homozygous allogeneic bone marrow for induction of tolerance with antilymphocyte serum: dose and timing.
    Wood ML; Monaco AP; Gozzo JJ; Liegeois A
    Transplant Proc; 1971 Mar; 3(1):676-9. PubMed ID: 4398508
    [No Abstract]   [Full Text] [Related]  

  • 36. 'Resistance' to unrelated, DLA-nonidentical canine marrow grafts is unrestricted by the major histocompatibility complex.
    Raff RF; Sandmaier BM; Graham T; Loughran TP; Pettinger M; Storb R
    Exp Hematol; 1994 Aug; 22(9):893-7. PubMed ID: 8062888
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Effector mechanisms and graft-versus-host disease.
    Elkins WL
    Transplant Proc; 1978 Mar; 10(1):15-7. PubMed ID: 24906
    [No Abstract]   [Full Text] [Related]  

  • 38. Effect of prior blood transfusions on marrow grafts: abrogation of sensitization by procarbazine and antithymocyte serum.
    Storb R; Floersheim GL; Weiden PL; Graham TC; Kolb HJ; Lerner KG; Schroeder ML; Thomas ED
    J Immunol; 1974 Apr; 112(4):1508-16. PubMed ID: 4592604
    [No Abstract]   [Full Text] [Related]  

  • 39. Studies on heterologous antilymphocyte serum in mice. VII. Optimal cellular antigen for induction of immunologic tolerance with antilymphocyte serum.
    Monaco AP; Wood ML
    Transplant Proc; 1970 Dec; 2(4):489-96. PubMed ID: 4939696
    [No Abstract]   [Full Text] [Related]  

  • 40. Enhanced survival of canine renal allografts of ALS- treated dogs given bone marrow.
    Caridis DT; Liegeois A; Barrett I; Monaco AP
    Transplant Proc; 1973 Mar; 5(1):671-4. PubMed ID: 4572126
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.